MedPath

A randomised controlled trial of the effects of reflexology on mood, coping and quality of life in women with early breast cancer

Completed
Conditions
Early breast cancer.
Cancer
Breast
Registration Number
ISRCTN87652313
Lead Sponsor
HS Research and Development National Cancer Programme (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
180
Inclusion Criteria

Newly diagnosed early breast cancer (T1, T2 <3 cm, N0, N1a, M0).

Exclusion Criteria

1. Unable to complete the study questionnaires
2. Unwilling to give written informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measures will be patient acceptability (number of sessions of reflexology actually attended) and scores on the Clinical Trials Index derived from the Functional Assessment of Cancer Therapy: Breast Version (FACT-B) at week 18.
Secondary Outcome Measures
NameTimeMethod
1. Mood Rating Scale (MRS)<br>2. Patient Satisfaction Questionnaire (PSQ)<br>3. FACT-B at week 24
© Copyright 2025. All Rights Reserved by MedPath